[Study of a new nicotinic acid derivative (Bradilan) with special reference to its tolerability].
D006801:Humans; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D014652:Vascular Diseases; D014665:Vasodilator Agents
D009539:Nicotinic Acids; D014665:Vasodilator Agents; D009525:Niacin; C100123:nicofuranose
NICOTINIC ACID; VASCULAR DISEASES; VASODILATOR AGENTS